Elnas, Hansel R.
HRN: 13-34-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/27/2025
04/03/2025
IV
900mg
Q8hrs
S/P CS With Hysterectomy + BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes